Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Workplace Drug Testing Service Market: By Sample Type, By Application, and Region Forecast 2020-2031
Workplace Drug Testing Service Market size was valued at US$ 5,289.8 million in 2024 and is expected to reach US$ 8,776.0 million by 2031, growing at a significant CAGR of 7.5% from 2025-2031. Workplace drug testing service is a testing process that is used to check the presence of any drugs or alcohol in the system of employees or applicants appearing for a job. As part of the job application process, many companies require candidates to undergo drug testing before receiving a job offer.
The rising legal and regulatory requirements are a significant driver for the increased revenues of the market. With the rising focus on creating drug-free workplaces, several federal laws and regulations, such as the Drug-free Workplace Act of 1988, are being imposed by the regulatory bodies. If a worker consumes drugs or alcohol, their reaction times, coordination, concentration, judgment, and work performance are likely to be impaired, which ultimately will decrease productivity at work. Therefore, companies are adopting several drug-free workplace programs, which in turn drive the growth of the market.
Furthermore, the rising safety and liability concerns are another significant driver behind the sales of workplace drug testing services. Workplace health and safety is one of the greatest responsibilities of both employers as well as employees. Drug and alcohol abuse can result in higher rates of accidents, incidents, and injury due to worker impairment. Poor judgment and carelessness lead to unnecessary risks for both the employee under the influence and others. By adopting drug testing services, employers can ensure the safety of their employees in the workplace and comply with the Health and Safety at Work Act 2015. This rising workplace safety concern has increased the use of workplace drug testing service, which in turn drive the growth of the market.
However, the high cost of workplace drug testing services stands as a potential restraint to the market growth. Meanwhile, the increase in workplace culture and safety initiatives and rising investments by the government across the globe can create significant opportunities for the growth of the market over the forecasted years. The key players in the market are further contributing to the development of the market by announcing launches, collaborations, and acquisitions. For instance, in November 2022, Marshall Health and Mountain Health Network launched new drug testing services for employers and healthcare providers.
Study Period
2024 -2030Base Year
2024CAGR
7.5%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
Industry-specific needs are a significant driver of growth in the workplace drug testing service market. Creating a drug-free workplace is increasingly crucial in safety-critical businesses such as scaffolding, logistics, railways, and construction where employee drug or alcohol consumption may cause significant harm in the workplace. Hence, the regulatory bodies are imposing several regulations and encouraging to adoption of workplace drug testing services to promote a drug-free workplace.
In addition, the rising demand for pre-employment screening in workplaces is another driver behind the development of workplace drug testing services. The consumption of alcohol by employees has a direct impact on their performance in the workplace, which ultimately affects the overall productivity of the businesses. This concern has mandated the adoption of workplace drug testing services during the recruitment process as well as for Periodic workplace drug testing particularly in safety-critical industries.
Report Benchmarks |
Details |
Report Study Period |
2024 -2030 |
Market Size in 2024 |
US$ 5,289.8 million |
Market Size in 2031 |
US$ 8,776.0 million |
Market CAGR |
7.5% |
By Sample Type |
|
By Application |
|
By Region |
|
Download Free Sample Report
Workplace Drug Testing Service Market size was valued at US$ 5,289.8 million in 2024 and is expected to reach US$ 8,776.0 million by 2031, growing at a significant CAGR of 7.5% from 2025-2031.
The rising focus on workplace safety, increasing stringent regulatory environments, and rising awareness create potential opportunities for the growth of the market.
The rising focus on research and development activities to improve the efficiency of workplace drug testing service solutions is one of the major trends in the market.
Abbott Laboratories (Alere Inc.), Quest Diagnostics Incorporated, Clinical Reference Laboratory, Laboratory Corporation, Cordant Health Solutions, Acm Global Laboratories, Omega Laboratories, Psychemedics, Millennium Health, Mayo Clinic Laboratories, Precision Diagnostics are a few companies operating in market.
1. Executive Summary |
2. Global Workplace Drug Testing Service Market Introduction |
2.1.Global Workplace Drug Testing Service Market - Taxonomy |
2.2.Global Workplace Drug Testing Service Market - Definitions |
2.2.1.Type |
2.2.2.Application |
2.2.3.Region |
3. Global Workplace Drug Testing Service Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Workplace Drug Testing Service Market Analysis, 2020 - 2024 and Forecast 2025 - 2031 |
4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Workplace Drug Testing Service Market By Type , 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
5.1. Urine Drug Testing |
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Oral Fluid Drug Testing |
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Hair Drug Testing |
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Workplace Drug Testing Service Market By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
6.1. Hospital Laboratories |
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Clinical Laboratories |
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Others |
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Workplace Drug Testing Service Market By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. North America Workplace Drug Testing Service Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
8.1. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Urine Drug Testing |
8.1.2.Oral Fluid Drug Testing |
8.1.3.Hair Drug Testing |
8.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1. Hospital Laboratories |
8.2.2.Clinical Laboratories |
8.2.3.Others |
8.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9. Europe Workplace Drug Testing Service Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Urine Drug Testing |
9.1.2.Oral Fluid Drug Testing |
9.1.3.Hair Drug Testing |
9.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Hospital Laboratories |
9.2.2.Clinical Laboratories |
9.2.3.Others |
9.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
9.3.6.Rest of EU |
10. Asia Pacific (APAC) Workplace Drug Testing Service Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Urine Drug Testing |
10.1.2.Oral Fluid Drug Testing |
10.1.3.Hair Drug Testing |
10.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Hospital Laboratories |
10.2.2.Clinical Laboratories |
10.2.3.Others |
10.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11. Middle East and Africa (MEA) Workplace Drug Testing Service Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Urine Drug Testing |
11.1.2.Oral Fluid Drug Testing |
11.1.3.Hair Drug Testing |
11.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Hospital Laboratories |
11.2.2.Clinical Laboratories |
11.2.3.Others |
11.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12. Latin America Workplace Drug Testing Service Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Urine Drug Testing |
12.1.2.Oral Fluid Drug Testing |
12.1.3.Hair Drug Testing |
12.2. Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Hospital Laboratories |
12.2.2.Clinical Laboratories |
12.2.3.Others |
12.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.Abbott Laboratories (Alere Inc.) |
13.2.2.Quest Diagnostics Incorporated |
13.2.3.Clinical Reference Laboratory |
13.2.4.Laboratory Corporation |
13.2.5.Cordant Health Solutions |
13.2.6.Acm Global Laboratories |
13.2.7.Omega Laboratories |
13.2.8.Psychemedics |
13.2.9.Millennium Health |
13.2.10.Mayo Clinic Laboratories |
13.2.11.Precision Diagnostics |
14. Research Methodology |
15. Appendix and Abbreviations |
Key Market Players